A fixed-effects model was used for meta-analysis, and the results showed no significant correlation between FTO expression and gender in gastric cancer patients (OR = 0.92, 95% CI: 0.74–1.14, P = .432) (Fig. 2). The gene discussed is FTO; the disease is gastric cancer.